Blog Detail
Pathophilia
http://www.pathophilia.com
Pathophilia provides daily medical and pharma-related news and commentary from a physician/writer.
- Added on: Mar 6th, 2008
- Country: United States
- Language: English
- Author: B. Martin, MD
- Listed in: Medicine
- Tags: medicine health care pharmaceuticals pathophilia
Recent Posts
Kick-Back Friday: #96
The Racket (1951): Howard Hughes remakes his 1928 film of the same name, which was based on Capone-inspired play. (Unfortunately the earlier film, which is reportedly better, is not on DVD.) Certain aspects of the reworked plot don't make......
BMJ Editor Bitch Slaps* Roche
What do we want? Raw data! When do we want it? Now! In the midst of the 2009 pandemic influenza epidemic, BMJ editor Fiona Godlee takes Roche to task for not supplying the necessary data to confirm or refute......
Tasigna Outperforms Gleevec in Open-Label Study of Ph+ CML, But Survival Data Absent
Nilotinib (Tasigna; Novartis) may be poised to become first-line treatment for Philadelphia-chromosome-positive (Ph+) chronic myeloid leukemia (CML), like its sister drug imatinib (Gleevec; Novartis). In a company-funded, open-label, random...
Spending Rally on DTC Drug Ads?
For what it's worth (perhaps a teeny-tiny indicator of an economic rebound?), pharma's spending on direct-to-consumer (DTC) advertising increased substantially during the third quarter of this year, to about $1.26 billion according to data from TNS M...
Measles Initiative Needs Funds to Avert Rise in Measles Deaths
Lack of funds may stall the Measles Initiative, a multi-organization program designed to reduce the worldwide mortality of measles. Despite the fact that all regions, except for Southeast Asia, have achieved the United Nations goal of reducing measle...
Pandemic Flu Vaccines Comparably Safe
Vaccines for pandemic influenza appear to be as safe as current seasonal influenza vaccines, reports the CDC. The Center's preliminary assessment of safety reports from the US Vaccine Adverse Events Reporting System (VAERS) and the Vaccine ...
